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Abstract
Background: Drawing Archimedes spirals is a popular and valid method of assessing action tremor in the upper limbs. We performed the first blinded comparison
of Fahn–Tolosa–Marı́n (FTM) ratings and tablet measures of essential tremor to determine if a digitizing tablet is better than 0–4 ratings in detecting changes in
essential tremor that exceed random variability in tremor amplitude.
Methods: The large and small spirals of FTM were drawn with each hand on two consecutive days by 14 men and four women (age 60¡8.7 years [mean¡SD])
with mild to severe essential tremor. The drawings were simultaneously digitized with a digitizing tablet. Tremor in each digitized drawing was computed with
spectral analysis in an independent laboratory, blinded to the clinical ratings. The mean peak-to-peak tremor displacement (cm) in the four spirals and mean FTM
ratings were compared statistically.
Results: Test–retest intraclass correlations (ICCs) (two-way random single measures, absolute agreement) were excellent for the FTM ratings (ICC 0.90, 95% CI
0.76–0.96) and tablet (ICC 0.97, 95% CI 0.91–0.99). Log10 tremor amplitude (T ) and FTM were strongly correlated (logT5aFTM + b, a<0.6, b<–1.27, r50.94).
The minimum detectable change for the tablet and FTM were 51% and 67% of the initial assessment.
Discussion: Digitizing tablets are much more precise than clinical ratings, but this advantage is mitigated by the natural variability in tremor. Nevertheless, the
digitizing tablet is a robust method of quantifying tremor that can be used in lieu of or in combination with clinical ratings.
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Introduction
Tremor rating scales provide crude, nonlinear, subjective assessments
of tremor severity.1 The Fahn–Tolosa–Marı́n (FTM) tremor rating
scale2 uses 0–4 anchors to assess tremor in drawings of Archimedes
spirals. The Bain and Findley scale uses 0–10 anchors.3 Both scales
have a strong logarithmic relationship with tremor amplitude mea-
sured with a digitizing tablet, consistent with the Weber–Fechner law
of psychophysics.4–7
Digitizing tablets are capable of providing linear objective measures
of tremor in writing and drawings.6,8–13 The Wacom Intuos 3 digi-
tizing tablet (www.wacom.com) has been used most commonly and has
an accuracy of ¡0.25 mm and a sampling frequency of 100 samples/s,
which are adequate for measuring the amplitude and frequency of a
tremor that is visible to the unaided eye.8,9 Digitizing tablets are unable
to detect pen motion when the pen tip is greater than 1 cm above the
tablet surface and lack sufficient sensitivity to measure physiologic
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tremor. Thus, tablets, like clinical ratings, have ceiling and floor effects
at the extremes of tremor amplitude.
The greater precision of tablets, relative to rating scales, enables one
to detect much smaller changes in tremor amplitude. However, this
advantage of tablets is diminished when random variability in tremor is
large. Tablets measure random variability precisely, but a change in
tremor must exceed random variability to be recognizable as a statis-
tically significant change resulting from treatment or disease progres-
sion (minimum detectable change).4,9 Therefore, we sought to determine
if a digitizing tablet is better than FTM part B spiral ratings in detecting
changes in essential tremor that exceed random variability in tremor
amplitude.
Methods
Twenty patients were enrolled in an unpublished open-label
pharmacokinetic–pharmacodynamic study of sodium oxybate for the
treatment of essential tremor, conducted by Jazz Pharmaceuticals.
Details of the study design can be found on ClinicalTrials.gov (https://
clinicaltrials.gov/ct2/show/study/NCT00598078). All patients parti-
cipated after giving their informed written consent, approved by a local
human subjects committee. The patients stopped all drugs for tremor
at least five half-lives before the study. They also abstained from
alcohol and caffeine for 48 hours. Fourteen men and four women
(age 60¡8.7 years [mean¡SD]) with mild to severe essential tremor
completed the study in which placebo or sodium oxybate was admin-
istered orally at 8 a.m. on three consecutive days. Baseline assessments
of tremor were performed each day between 7 and 8 a.m. Tremor was
quantified with the FTM rating scale and a digitizing tablet. All
patients were examined by the same neurologist (A.L.E.). The paper
with the large and small FTM spiral templates was mounted on a
Wacom Intuos 3 digitizing tablet so that the same drawings were rated
and digitized. Tremor amplitude in each digitized drawing was com-
puted in an independent central laboratory using spectral analysis. The
software used is available online.9 The technician performing the
tablet analyses was blinded to the tremor ratings and study design.
The grand average of mean peak-to-peak tremor displacement (cm)
in the four spirals (large and small spirals drawn with each hand) was
compared with the grand average of the four FTM spiral ratings.
A paired t test analysis of the baseline FTM spiral ratings and tablet
measures on days 1 and 2 revealed a statistically significant practice
effect or carryover effect from day 1 to day 2. The mean FTM spiral
rating decreased slightly (1.21 to 0.88, t5–3.011, p50.008), as did
the log-transformed tablet measure (geometric mean 0.28 to 0.20,
t5–2.431, p50.026). By contrast, the baseline FTM and tablet means
were statistically identical on days 2 and 3 (mean FTM spiral ratings,
0.88 and 0.94, t50.719, p50.48; geometric mean tablet measures,
0.20 to 0.19, t5–0.457, p50.65). We therefore used the data from
days 2 and 3 in this study to estimate test–retest reliability and MDC.
In this, study, baseline 1 refers to the baseline data from study day 2,
and baseline 2 refers to the data from study day 3. Baseline assessments
from these two days were used to compute test–retest reliability (two-
way random single measures intraclass correlations [ICCs], absolute
agreement) and minimum detectable change (MDC) for the FTM
spiral ratings and digitizing tablet measurements.14
MDC was computed using the formula MDC5SDd?1.96, where SDd
is the standard deviation of the differences for the two measurements.14
For the grand average of the four FTM spiral ratings, MDC was
expressed as a percentage of the baseline 1 mean (MDC%). The tablet
data were positively skewed, so log10 transformation was performed to
normalize these data. Note that SDd of log-transformed data is a ratio,
and the MDC is therefore also a ratio; they are not log SDd and log
MDC of the non-transformed data.15 MDC% of the log-transformed
data is expressed as a percentage of the baseline geometric mean, using
the equation MDC%5(12102MDC)?100.15 All statistical analyses were
performed with MedCalcH statistical software (www.medcalc.org).
Results
The mean spiral ratings did not differ statistically from a normal
distribution (D’Agostino–Pearson test: p50.16 for baseline 1 data and
p50.13 for baseline 2 data). The tablet data were positively skewed
and deviated significantly from a normal distribution (D’Agostino–
Pearson test: p,0.0001 for baseline 1 and 2 data), so log10 transformation
was performed to normalize these data, producing data that did not
deviate significantly from a normal distribution (D’Agostino–Pearson test:
p50.25 for baseline 1 data and p50.18 for baseline 2 data). The FTM
ratings exhibited a floor effect in this patient population (Figure 1).
Figure 1. Distributions of Mean FTM Spiral Ratings and Log Tremor Amplitudes. Notched box and whisker plots of mean FTM spiral ratings and
tablet measures are shown for the two baseline assessments. The baseline medians did not differ significantly for either measure of tremor severity. The FTM data
exhibit a floor effect at 0. FTM, Fahn–Tolosa–Marı́n.
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Regression analysis revealed a very strong linear Weber–Fechner
relationship (logT5a?FTM+b) between mean FTM spiral ratings and
log mean tablet tremor amplitudes T (cm) for baseline 1 and baseline 2
measurements (Figure 2). Test–retest ICC was excellent for the FTM
ratings (ICC 0.90, 95% CI 0.76 to 0.96) and log-transformed tablet
measures (ICC 0.97, 95% CI 0.91 to 0.99).
The MDC for the digitizing tablet was 51% of the baseline geometric
mean tremor amplitude (Table 1). The MDC for FTM was 90% of
mean baseline spiral rating. However, FTM is a non-linear ordinal scale,
so computing % change is not valid.5,16 Therefore, we converted FTM
to actual tremor amplitude using the average slope and intercept in
Figure 2 for the two regression equations relating FTM and log tremor
amplitude (average slope a50.6 and intercept b5–1.26), and we

















In the above calculations, SDd (–0.41) is the standard deviation of
the differences between the baseline 1 and baseline 2 FTM scores. This
estimate of MDC% (67%) is similar to that found for the tablet.
Our estimates of MDC% appear to be very robust and not
dependent on normalization of the data. We computed the MDC% of
the tablet data without log transformation, using the baseline 1 mean
(0.62 cm) and the SDd of the two baselines (0.20 cm). Using these
values, the MDC% is as follows:
MDC%~0:20:1:96:100=0:62~63% (2)
Discussion
This is the first blinded study demonstrating a strong correlation
between tablet and FTM spiral ratings, and this study provides much-
needed estimates of test-retest reliability and MDC% for tablet and
FTM spiral ratings. We have shown that tablet measures are highly
correlated with FTM tremor ratings. The test-retest ICC for the tablet
was only marginally better than the FTM ICC. However, the FTM
ICC probably would have been lower if different raters had been used
to assess the two baselines because intra-rater reliability is much better
than inter-rater reliability for tremor rating scales.1 Also, we compared
the average ratings and amplitudes of 4 spirals, and this is known to
reduce test–retest variability.17
Figure 2. Linear Regression Equations for Log10 Tremor Amplitude vs. FTM. Regression lines (blue) and 95% confidence intervals (red broken lines) are
shown for log mean tremor amplitude vs. mean FTM spiral rating for baseline 1 and 2 assessments. FTM, Fahn–Tolosa–Marı́n.











Baseline 1 0.88 0.41 0.20 0.164 90%1 51%3
Baseline 2 0.94 0.19 67%2
Abbreviations: FTM, Fahn–Tolosa–Marı́n; MDC, Minimum Detectable Change (SDd?1.96); SDd: Standard Deviation of the Differences.
1MDC%: percentage of baseline 1 mean FTM.
2MDC%: percentage of baseline 1 mean FTM, computed with the Weber–Fechner equations in Figure 2.
3MDC%: percentage of baseline 1 geometric mean.
4SDd of log-transformed data.
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Haubenberger and colleagues6 found a strong (r.0.9) logarithmic
relationship between tablet measures of tremor amplitude and the Bain
and Findley 0–10 ratings of tremor in Archimedes spirals, and the
slope of this relationship was 0.2436. From this relationship for 0–10
ratings, the slope for a 0–4 scale can be estimated as 0.2436?(10/4)5
0.601,16 which is what we found in this study. Thus, the logarithmic
relationship between tablet measures and tremor ratings is robust,
regardless of the scale that is used.
There is no published evidence that the Bain and Findley 0–10
ratings are more sensitive to change than FTM 0–4 ratings.1 Hopfner
and coworkers18 estimated the minimum detectable change of the Bain
and Findley scale to be 2 points, or 20% of the maximum rating 10.
We found the MDC of the mean FTM spiral rating to be 0.8 points,
which is 20% of the maximum rating 4.
Detectable change in essential tremor is limited by the considerable
natural variability of tremor amplitude over time. The variability in
tremor amplitude is so great that the MDC (the smallest detectable
change exceeding random variability) of the digitizing tablet is similar
to the MDC of the FTM 0–4 ratings and the Bain and Findley 0–10
ratings. Digitizing tablets are much more precise than clinical ratings,
but this advantage is mitigated by the natural variability in tremor.
Digitizing tablets have potential floor and ceiling effects. They
cannot measure tremor that is not visible because their accuracy is
roughly ¡0.25 mm. They also cannot record tremor that is so severe
that the pen tip does not remain within 1 cm of the tablet surface.
However, FTM ratings had an obvious floor effect in our patient
population, but the tablet exhibited no floor effect for these patients.
Tremor severity was not great enough in our patient cohort to
examine a ceiling effect for the tablet vs. FTM.
Nevertheless, the digitizing tablet is clearly a valid and robust
method of quantifying tremor. It can be used in lieu of, or in
combination with, clinical ratings of tremor in Archimedes spirals. The
tablet provides an accurate, clinically meaningful assessment of tremor
amplitude. These devices cost a few hundred dollars, and free software
for tremor analysis is available on the internet.6,9
Our study has limitations. Our estimates of test–retest reliability and
MDC% were computed using two baseline assessments at the same
time of the day on two consecutive days, while controlling for tremor
medications, caffeine, and alcohol. Random test–retest variability
might be greater if the interval between assessments was longer and if
the other controls were less stringent. Our results need to be confirmed
using baseline assessments at intervals of 1 week and 1 month, which
are common intervals of assessment in clinical trials.
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